Home » Topics » Regulatory » Patents

Patents
RSS

Novel gamma-aminobutyric acids related to gabapentin prepared at Warner-Lambert

July 28, 1998

Zeneca presents peptides for modifying autoimmune responses as in RA

July 27, 1998

Antitumor bis(acridinecarboxamide) and bis(phenazinecarboxamide) derivatives

July 27, 1998

Phosphonic acids that block EAA receptors: new series from Novartis

July 27, 1998

Zeria discovers agents for improving gastrointestinal motility

July 24, 1998

New PDE V inhibitors in development by Merck KGaA

July 24, 1998

Neuroprotective agents disclosed by Shionogi

July 24, 1998

Natural glutamate uptake inhibitors useful for memory disturbances

July 24, 1998

Dipeptidyl peptidase IV inhibitors developed at Tanabe

July 24, 1998

New series of neuroprotective compounds described by Nippon Chemiphar

July 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.